XL-418 is a selective, orally active small molecule, targeting protein kinase B (PKB or AKT) and ribosomal protein S6 Kinase (p70S6K), with potential antineoplastic activity. XL418 inhibits the activities of PKB and p70S6K, both acting downstream of phosphoinosotide-3 kinase (PI3K). These kinases are often upregulated in a variety of cancers. Inhibition of PKB by this agent will induce apoptosis, while inhibition of p70S6K will result in the inhibition of translation within tumor cells.
Molecular Weight:
609.48
CAS Number:
[871343-09-8]
Formula:
C26H32BrF3N8O
Target:
Others
T68477
* VAT and and shipping costs not included. Errors and price changes excepted
